Post-COVID-19 and other changes in the health status of children and adolescents associated with the transmission of COVID-19
Abstract
determining the state of physical and psycho-emotional health of children and adolescents who have suffered from COVID-19 is an urgent diagnostic problem, the solution of which will provide an opportunity for early detection of long-term and distant consequences of the coronavirus disease. The aim is to analyze the frequency, duration, and clinical manifestations of post-COVID-19 in children and adolescents, as well as other changes in health status associated with having experienced COVID-19. Materials and methods: 155 children aged 6 to 18 took part in the study. Among them, 120 children with a confirmed diagnosis of COVID-19 in the anamnesis and a period after COVID-19 of more than 12 weeks (the main group) and 35 somatically healthy children of the same age who did not suffer from COVID-19 and formed the control group. The distribution of children in the main group took place taking into account the severity of COVID-19. Children who contracted mild COVID-19 formed the first group (n=49). Group II included children who suffered from COVID-19 of moderate severity (n=40). Group III included children who contracted COVID-19 with a severe course (n=31). General clinical (analysis of anamnesis data, objective examination, assessment of complaints and identification of post-covid symptoms), survey (assessment of the general state of health of children before and after COVID-19, assessment of the level of fatigue), statistical research methods (MedStat statistical packages, EZR). Results: post-COVID-19 was detected in 46 children (38.3%) of the main group. Among the children of the I group, the post-COVID-19 condition was determined in 10 children (20.4%), in the II group - in 14 (35.0%) children, and the III group - in 22 (71.0%) children. The median duration of the post-COVID-19 in the children of the I group was 3.5 months [3; 4], in the II group - 5 months, in the III group - 7 months (p<0.05 between groups when performing multiple comparisons according to Dunn's test). The median duration of post-COVID-19 symptoms in children of the main group was 5 months. The average value (X) and standard deviation (±SD) of the number of symptoms of post-COVID-19 in children of the main group were 5.17±2.7 symptoms: in children of the I group - 1.70±0.82 symptoms, in the II group - 4,29±1.38 symptoms, in the III group - 7.32±1.76 symptoms. The most frequently recorded post-COVID-19 symptoms were anxiety (15; 95% CI 9.1-22.0), increased fatigue (13.3; 95% CI 7.8-20.0), sleep disturbances (12 .5; 95% CI 7.2-19.1), depressive disorders (11.7; 95% CI 6.5-18.1), impaired concentration of attention (10.8; 95% CI 5.9-17,1). Analysis of survey data on changes in physical and psychological/emotional health status revealed a worsening of outcomes after COVID-19 compared to the period before coronavirus disease. The median score on the Chalder fatigue scale in the children of the main group was 12, in the control group – 7 (p<0.001 by the Wilcoxon W-test for two independent samples). Conclusions: Acute COVID-19 harms the health of children and adolescents, which can be manifested by the development of a post-COVID-19. The risk of developing post-COVID-19 depends on the degree of severity of the transferred coronavirus disease. The post-COVID-19 condition was detected in 71% of children who suffered from severe COVID-19, which is significantly higher compared to children who suffered from COVID-19 of mild and moderate severity. Children with COVID-19 scored worse on the Chalder Fatigue Scale than healthy children. There was also a tendency to worsen the assessment of the health status of children in a comparative analysis of the physical and psychological/emotional components before and after COVID-19.
References
BBehnood SA, Shafran R, Bennett SD, et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies. J Infect. 2022;84:158–70.
Borch, L., Holm, M., Knudsen, M., Ellermann-Eriksen, S., & Hagstroem, S. (2022). Long COVID symptoms and duration in SARS-CoV-2 positive children—a nationwide cohort study. European journal of pediatrics, 181(4), 1597-1607.
Buonsenso, D., Gennaro, L. D., Rose, C. D., Morello, R., D'Ilario, F., Zampino, G., ... & Valentini, P. (2022). Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid. Future microbiology, 17(7), 551-571.
Cella, M., & Chalder, T. (2010). Measuring fatigue in clinical and community settings. Journal of psychosomatic research, 69(1), 17–22.
Funk AL, Kuppermann N, Florin TA, et al. Pediatric Emergency Research Network–COVID-19 Study Team. Post-COVID-19 conditions among children 90 days after SARS-CoV-2 infection. JAMA Netw Open. 2022;5:e2223253.
Gupta, M., Gupta, N., & Esang, M. (2022). Long COVID in Children and Adolescents. The primary care companion for CNS disorders, 24(2), 21r03218.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–458.
Koloskova, O. K., Kramarov, S. O., Bilous, T. M., Ivanova, L. A., Kaminska, T. M., Nezghoda, I. I., ... & Lobortas, Yu. I. (2021). Osoblyvosti perebihu koronavirusnoi infektsii COVID-19 u ditei Ukrainy; Rechkina COVID-19 ta postkovidnyi syndrom u ditei z bronkhialnoiu astmoiu
Kumar, P., & Jat, K. R. (2023). Post-COVID-19 Sequelae in Children. Indian Journal of Pediatrics, 90(6), 605-611.
Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12:9950.
Marushko YuV, Dmytryshyn OA. (2023). Evaluation of the effectiveness of the magnesium-potassium complex in correcting the health status of children who have suffered from COVID-19. Modern Pediatrics. Ukraine. 4(132): 7-15.
Morello R, Martino L, Buonsenso D. Diagnosis and management of post-COVID (Long COVID) in children: a moving target. Curr Opin Pediatr. 2023 Apr 1;35(2):184-192. doi: https://doi.org/10.1097/MOP.0000000000001221. Epub 2023 Jan 23. PMID: 36660968; PMCID: PMC9994801.
Pellegrino, R., Chiappini, E., Licari, A., Galli, L., & Marseglia, G. L. (2022). Prevalence and clinical presentation of long COVID in children: a systematic review. European journal of pediatrics, 181(12), 3995–4009.
Pereira, S. M. P., Nugawela, M. D., Rojas, N. K., Shafran, R., McOwat, K., Simmons, R., ... & Stephenson, T. (2023). Post-COVID-19 condition at 6 months and COVID-19 vaccination in non-hospitalised children and young people. Archives of Disease in Childhood, 108(4), 289-295.
Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021;326:869–71.
Stephenson, T., Allin, B., Nugawela, M. D., Rojas, N., Dalrymple, E., Pinto Pereira, S., Soni, M., Knight, M., Cheung, E. Y., Heyman, I., CLoCk Consortium, & Shafran, R. (2022). Long COVID (post-COVID-19 condition) in children: a modified Delphi process. Archives of disease in childhood, 107(7), 674–680.
Stephenson T, Shafran R, De Stavola B, et al. CLoCk Consortium members. Long COVID and the mental and physical health of children and young people: National matched cohort study protocol (the CLoCk study). BMJ Open. 2021;11:e052838.
Sykes, D. L., Holdsworth, L., Jawad, N., Gunasekera, P., Morice, A. H., & Crooks, M. G. (2021). Post-COVID-19 symptom burden: What is long-COVID and how should we manage it?. Lung, 199(2), 113-119.
Zimmermann P, Pittet LF, Curtis N. How Common is Long COVID in Children and Adolescents? Pediatr Infect Dis J. 2021 Dec 1;40(12):e482-e487. https://doi.org/10.1097/INF.0000000000003328. PMID: 34870392; PMCID: PMC8575095.

This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN
ISSN 












